RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ)...
Gespeichert in:
| Veröffentlicht in: | Archives of virology 2021-03, Vol.166 (3), p.949-954 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 954 |
|---|---|
| container_issue | 3 |
| container_start_page | 949 |
| container_title | Archives of virology |
| container_volume | 166 |
| creator | Dabbous, Hany M. Abd-Elsalam, Sherief El-Sayed, Manal H. Sherief, Ahmed F. Ebeid, Fatma F. S. El Ghafar, Mohamed Samir Abd Soliman, Shaimaa Elbahnasawy, Mohamed Badawi, Rehab Tageldin, Mohamed Awad |
| description | No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patients in the favipiravir group needed mechanical ventilation (
p
= 0.129). One patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (
p
= 1.00). Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.
ClinicalTrials.gov Identifier NCT04351295. |
| doi_str_mv | 10.1007/s00705-021-04956-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2489439410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489439410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2089-5648208ca2110ea2b1e5b20b8cd73ba7d098ebc96e6d03523418aa509b24d5ab3</originalsourceid><addsrcrecordid>eNp9UF1LwzAUDaLgnP4BnwI-R2_StE32Nrqqg8FgVF9DmqbSsbYzaYX5641W8M2Xcz8459zLQeiWwj0FSB98AIgJMEqAyzgh8gzNKI8YEakU52gGEXAiEhCX6Mr7PUBYRPEM6V1e7JZZka_wcless02-wHldN0abE-5rXOuP5ti4gA43Hc62r-sVoRIPzuqhtd2wwBq342FoiAmTddjprurb5tNW2A9jdbpGF7U-eHvzW-fo5TEvsmey2T6ts-WGGAZCkjjhIjRGM0rBalZSG5cMSmGqNCp1WoEUtjQysUkVPmcRp0LrGGTJeBXrMpqju8n36Pr30fpB7fvRdeGkYlxIHklOIbDYxDKu997ZWh1d02p3UhTUd5RqilKFKNVPlEoGUTSJfCB3b9b9Wf-j-gI-j3QJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489439410</pqid></control><display><type>article</type><title>RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study</title><source>Springer Nature - Complete Springer Journals</source><creator>Dabbous, Hany M. ; Abd-Elsalam, Sherief ; El-Sayed, Manal H. ; Sherief, Ahmed F. ; Ebeid, Fatma F. S. ; El Ghafar, Mohamed Samir Abd ; Soliman, Shaimaa ; Elbahnasawy, Mohamed ; Badawi, Rehab ; Tageldin, Mohamed Awad</creator><creatorcontrib>Dabbous, Hany M. ; Abd-Elsalam, Sherief ; El-Sayed, Manal H. ; Sherief, Ahmed F. ; Ebeid, Fatma F. S. ; El Ghafar, Mohamed Samir Abd ; Soliman, Shaimaa ; Elbahnasawy, Mohamed ; Badawi, Rehab ; Tageldin, Mohamed Awad</creatorcontrib><description>No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patients in the favipiravir group needed mechanical ventilation (
p
= 0.129). One patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (
p
= 1.00). Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.
ClinicalTrials.gov Identifier NCT04351295.</description><identifier>ISSN: 0304-8608</identifier><identifier>EISSN: 1432-8798</identifier><identifier>DOI: 10.1007/s00705-021-04956-9</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Infectious Diseases ; Medical Microbiology ; Virology</subject><ispartof>Archives of virology, 2021-03, Vol.166 (3), p.949-954</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, AT part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, AT part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2089-5648208ca2110ea2b1e5b20b8cd73ba7d098ebc96e6d03523418aa509b24d5ab3</citedby><cites>FETCH-LOGICAL-c2089-5648208ca2110ea2b1e5b20b8cd73ba7d098ebc96e6d03523418aa509b24d5ab3</cites><orcidid>0000-0003-4366-2218</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00705-021-04956-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00705-021-04956-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Dabbous, Hany M.</creatorcontrib><creatorcontrib>Abd-Elsalam, Sherief</creatorcontrib><creatorcontrib>El-Sayed, Manal H.</creatorcontrib><creatorcontrib>Sherief, Ahmed F.</creatorcontrib><creatorcontrib>Ebeid, Fatma F. S.</creatorcontrib><creatorcontrib>El Ghafar, Mohamed Samir Abd</creatorcontrib><creatorcontrib>Soliman, Shaimaa</creatorcontrib><creatorcontrib>Elbahnasawy, Mohamed</creatorcontrib><creatorcontrib>Badawi, Rehab</creatorcontrib><creatorcontrib>Tageldin, Mohamed Awad</creatorcontrib><title>RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study</title><title>Archives of virology</title><addtitle>Arch Virol</addtitle><description>No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patients in the favipiravir group needed mechanical ventilation (
p
= 0.129). One patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (
p
= 1.00). Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.
ClinicalTrials.gov Identifier NCT04351295.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Infectious Diseases</subject><subject>Medical Microbiology</subject><subject>Virology</subject><issn>0304-8608</issn><issn>1432-8798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9UF1LwzAUDaLgnP4BnwI-R2_StE32Nrqqg8FgVF9DmqbSsbYzaYX5641W8M2Xcz8459zLQeiWwj0FSB98AIgJMEqAyzgh8gzNKI8YEakU52gGEXAiEhCX6Mr7PUBYRPEM6V1e7JZZka_wcless02-wHldN0abE-5rXOuP5ti4gA43Hc62r-sVoRIPzuqhtd2wwBq342FoiAmTddjprurb5tNW2A9jdbpGF7U-eHvzW-fo5TEvsmey2T6ts-WGGAZCkjjhIjRGM0rBalZSG5cMSmGqNCp1WoEUtjQysUkVPmcRp0LrGGTJeBXrMpqju8n36Pr30fpB7fvRdeGkYlxIHklOIbDYxDKu997ZWh1d02p3UhTUd5RqilKFKNVPlEoGUTSJfCB3b9b9Wf-j-gI-j3QJ</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Dabbous, Hany M.</creator><creator>Abd-Elsalam, Sherief</creator><creator>El-Sayed, Manal H.</creator><creator>Sherief, Ahmed F.</creator><creator>Ebeid, Fatma F. S.</creator><creator>El Ghafar, Mohamed Samir Abd</creator><creator>Soliman, Shaimaa</creator><creator>Elbahnasawy, Mohamed</creator><creator>Badawi, Rehab</creator><creator>Tageldin, Mohamed Awad</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0003-4366-2218</orcidid></search><sort><creationdate>20210301</creationdate><title>RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study</title><author>Dabbous, Hany M. ; Abd-Elsalam, Sherief ; El-Sayed, Manal H. ; Sherief, Ahmed F. ; Ebeid, Fatma F. S. ; El Ghafar, Mohamed Samir Abd ; Soliman, Shaimaa ; Elbahnasawy, Mohamed ; Badawi, Rehab ; Tageldin, Mohamed Awad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2089-5648208ca2110ea2b1e5b20b8cd73ba7d098ebc96e6d03523418aa509b24d5ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Infectious Diseases</topic><topic>Medical Microbiology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dabbous, Hany M.</creatorcontrib><creatorcontrib>Abd-Elsalam, Sherief</creatorcontrib><creatorcontrib>El-Sayed, Manal H.</creatorcontrib><creatorcontrib>Sherief, Ahmed F.</creatorcontrib><creatorcontrib>Ebeid, Fatma F. S.</creatorcontrib><creatorcontrib>El Ghafar, Mohamed Samir Abd</creatorcontrib><creatorcontrib>Soliman, Shaimaa</creatorcontrib><creatorcontrib>Elbahnasawy, Mohamed</creatorcontrib><creatorcontrib>Badawi, Rehab</creatorcontrib><creatorcontrib>Tageldin, Mohamed Awad</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><jtitle>Archives of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dabbous, Hany M.</au><au>Abd-Elsalam, Sherief</au><au>El-Sayed, Manal H.</au><au>Sherief, Ahmed F.</au><au>Ebeid, Fatma F. S.</au><au>El Ghafar, Mohamed Samir Abd</au><au>Soliman, Shaimaa</au><au>Elbahnasawy, Mohamed</au><au>Badawi, Rehab</au><au>Tageldin, Mohamed Awad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study</atitle><jtitle>Archives of virology</jtitle><stitle>Arch Virol</stitle><date>2021-03-01</date><risdate>2021</risdate><volume>166</volume><issue>3</issue><spage>949</spage><epage>954</epage><pages>949-954</pages><issn>0304-8608</issn><eissn>1432-8798</eissn><abstract>No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patients in the favipiravir group needed mechanical ventilation (
p
= 0.129). One patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (
p
= 1.00). Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.
ClinicalTrials.gov Identifier NCT04351295.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><doi>10.1007/s00705-021-04956-9</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4366-2218</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0304-8608 |
| ispartof | Archives of virology, 2021-03, Vol.166 (3), p.949-954 |
| issn | 0304-8608 1432-8798 |
| language | eng |
| recordid | cdi_proquest_journals_2489439410 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Biomedical and Life Sciences Biomedicine Brief Report Infectious Diseases Medical Microbiology Virology |
| title | RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T10%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RETRACTED%20ARTICLE:%20Efficacy%20of%20favipiravir%20in%20COVID-19%20treatment:%20a%20multi-center%20randomized%20study&rft.jtitle=Archives%20of%20virology&rft.au=Dabbous,%20Hany%20M.&rft.date=2021-03-01&rft.volume=166&rft.issue=3&rft.spage=949&rft.epage=954&rft.pages=949-954&rft.issn=0304-8608&rft.eissn=1432-8798&rft_id=info:doi/10.1007/s00705-021-04956-9&rft_dat=%3Cproquest_cross%3E2489439410%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489439410&rft_id=info:pmid/&rfr_iscdi=true |